What's breaking now, across thousands of outlets.
Older Americans are increasingly taking multiple prescription medications and dietary supplements. Although the prevalence of potentially major drug-drug interactions has declined slightly, more than 1 in 5 older adults are potentially at risk, according to a USC-led study published in JAMA.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
The anti-abortion group Students for Life America on Thursday filed a notice of intent to sue the Food and Drug Administration over alleged inaction over the Endangered Species Act, an escalation of…
The FDA has classified Vitruvias Therapeutics' recall of thyroid tablets as Class I due to potential superpotency, posing a risk of serious health issues.
UnitedHealth Group has named Jodee Kozlak to the newly-created role of chief administrative officer, the healthcare giant announced Thursday morning.
A new study led by UCLA Health found that a large percentage of disadvantaged patients are not taking their diabetes medications consistently.
Pixel Watch's new Health Guardian feature brings BP, insulin resistance, and sleep quality trends.
The FDA approved Elevar Therapeutics’ Lyrfigtu as a second-line treatment option for certain patients with bile duct cancer, which is diagnosed in about 8,000 Americans each year.
